Physician profile
James E Creech
NPI 1750431987
$4,572.68
in general payments reported to CMS, 2019-2025
17 companies · $480 in 2025
The $480 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $200 · 2021: $707 · 2022: $561 · 2023: $181 · 2024: $1,951 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,308 · Travel and Lodging: $1,203 · Entertainment: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.13 |
| Travel and Lodging | $1,203.18 |
| Entertainment | $100.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,464.46 | 2020-2025 | Tryptyr, Precision 1, Dailies Total1 |
| Coopervision INC. | $437.13 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $254.08 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $176.25 | 2024 | Xdemvy |
| Allergan, INC. | $161.98 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $142.32 | 2021-2022 | |
| Lkc Technologies, INC. | $130.31 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $126.19 | 2019 | |
| Dompe US, INC. | $125.00 | 2021 | |
| Glaukos Corporation | $122.94 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.29 | 2019 | |
| Abbvie INC. | $110.90 | 2022-2023 | Vuity |
| Maculogix, INC. | $81.99 | 2019 | |
| Lombart Brothers, INC. | $60.38 | 2025 | Opd-III |
| Tearlab Corp | $22.68 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $21.16 | 2025 | Scoutpro Osmolarity System |
| Oyster Point Pharma, INC. | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Creech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.